113 related articles for article (PubMed ID: 212822)
1. Human leucocyte migration inhibitory factor (LIF). V. Specific regulation of the lymphokine serine protease activity by 3',5'-cGMP and, possibly, 2',3'-cCMP.
Bendtzen K
Scand J Immunol; 1978; 8(1):53-61. PubMed ID: 212822
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificity of the human lymphokine leucocyte migration-inhibitory factor (LIF): radioenzymic assay and inhibition by cGMP.
Bendtzen K
Scand J Immunol; 1979; 10(1):61-7. PubMed ID: 224450
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluoride.
Bendtzen K
Scand J Immunol; 1977; 6(12):1357-61. PubMed ID: 203999
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
[TBL] [Abstract][Full Text] [Related]
5. Increased polymorphonuclear leukocyte cGMP levels induced by the human lympholine, leukocyte migration inhibitory factor (LIF).
Bendtzen K; Klysner R
Immunopharmacology; 1979 Jul; 1(4):323-30. PubMed ID: 233586
[TBL] [Abstract][Full Text] [Related]
6. In vitro modulation of human leucocyte migration and migration inhibitory factor (LIF) activity by cyclic 3',5'-AMP and cyclic 3',5'-GMP.
Bendtzen K; Palit J
Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):78-80. PubMed ID: 190856
[TBL] [Abstract][Full Text] [Related]
7. cAMP, cGMP, cCMP and cUMP concentrations across the tree of life: High cCMP and cUMP levels in astrocytes.
Hartwig C; Bähre H; Wolter S; Beckert U; Kaever V; Seifert R
Neurosci Lett; 2014 Sep; 579():183-7. PubMed ID: 25062586
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
[TBL] [Abstract][Full Text] [Related]
9. Use of benzoyl-L-phenylalanyl-L-valyl-L-arginine (3H) methyl ester as a sensitive and selective substrate for the human lymphokine, leukocyte migration inhibitory factor (LIF).
Bendtzen K; Rocklin RE
J Immunol; 1980 Oct; 125(4):1775-81. PubMed ID: 6251137
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of the human lymphokine leukocyte migration inhibitory factor (LIF): role of cGMP as a specific inhibitor of the LIF esterase activity.
Bendtzen K
Adv Exp Med Biol; 1979; 114():485-90. PubMed ID: 223417
[No Abstract] [Full Text] [Related]
11. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
Bendtzen K
J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
[TBL] [Abstract][Full Text] [Related]
12. Influence of cyclic nucleotides, norepinephrine and calcium on 3H-uridine incorporation into RNA in thyroid slices.
Kleiman de Pisarev DL; Pisarev MA; Juvenal GJ
Acta Physiol Pharmacol Latinoam; 1984; 34(1):31-6. PubMed ID: 6206682
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide-induced inhibition of surface sialyl transferase activity on cultured Burkitt's lymphoma cells.
Kilton LJ; Maca RD
J Natl Cancer Inst; 1977 May; 58(5):1479-81. PubMed ID: 192903
[TBL] [Abstract][Full Text] [Related]
14. Medicinal Chemistry of the Noncanonical Cyclic Nucleotides cCMP and cUMP.
Schwede F; Rentsch A; Genieser HG
Handb Exp Pharmacol; 2017; 238():307-337. PubMed ID: 27896476
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides.
Wolter S; Golombek M; Seifert R
Biochem Biophys Res Commun; 2011 Dec; 415(4):563-6. PubMed ID: 22074826
[TBL] [Abstract][Full Text] [Related]
17. Unspecific and specific stimulating effects of 3',5'-cyclic nucleotides (cGMP, cAMP, cIMP, cCMP) on the in vitro biosynthesis of proteochondroitin-4,-6-sulfate and on other anabolic processes from calf rib cartilage.
Kleine TO; Schippers K
Agents Actions; 1978 Dec; 8(6):636-43. PubMed ID: 217257
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
Bendtzen K
Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of glucose transport in rat cardiac myocytes by guanosine 3',5'-monophosphate.
Shanahan MF; Edwards BM
Endocrinology; 1989 Aug; 125(2):1074-81. PubMed ID: 2546735
[TBL] [Abstract][Full Text] [Related]
20. cCMP and cUMP: emerging second messengers.
Seifert R
Trends Biochem Sci; 2015 Jan; 40(1):8-15. PubMed ID: 25435399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
